|
|
 |
|
Viewing report
|
|
|
|
Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China
Frost & Sullivan, July 2005
International Pharmaceutical Companies Develop Research Base in India and China
Beleaguered by ever-increasing cost pressures, shorter product life cycles and various regulatory challenges in the West, the pharmaceutical industry is turning to opportunities in low-cost Asian countries such as India and China. Alliances with local companies, contractual outsourcing arrangements and establishment of local subsidiaries enable these enterprises to access openings in both countries, especially in the area of pharmaceutical research and development (R&D).
This service analyses the advantages and disadvantages of pharma R&D outsourcing to India and China. The study discusses the various trends and opportunities in each country while providing in-depth market share analysis, forecasts, drivers, restraints, and revenue forecasts. It also enables companies to align their positioning strategies to benefit from the changing environment and obtain maximum return on investment.
Customers who bought this item also bought
India: Pharmaceutical and biotechnology opportunities
Pharmaceutical Outsourcing Strategies: Market Expansion, Offshoring and Strategic Management in the CRO and CMO Marketplace
Opportunities for European Pharmaceutical and Biotechnology Companies in Indian and Chinese Markets
BioMed Outsourcing Report-Drug Discovery Partnerships-The Indian Biopharmaceutical Outsourcing Sector
Indian Pharmaceutical Industry: Issues and Opportunities
Pharmaceutical Outsourcing Part 2: An Introduction to Drug Discovery Strategies � New Opportunities Lie In A Fully Integrated Global Outsourcing Strategy
The Pharmaceutical Market Outlook to 2015: Implementing innovative, long-term strategies for sustainable future growth
Over-the-Counter Pharmaceuticals in China: Company Profiles 2006
|
|
|
|
